11,067 followers
🩺💊ESTUDIO QUE REPORTA LA EFICACIA, SEGUIRIDAD Y FARMACOCINÉTICA DE RECATICIMAB AÑADIDO A ATORVASTATINA PARA LA DISMINUCIÓN DE LOS NIVELES DE COLESTEROL LDL. 📉 https://t.co/yGwZwl2ZBq. https://t.co/K1Iw3EGdvM
398 followers
Recaticimab agregado a estatinas a intensidad moderada reduce significativa y sustancialmente el nivel de LDL incluso cada 12 sem o placebo #recaticimab #PCSK9 #LDL https://t.co/AMEOD0yxCh
29,275 followers
RT @VietHeartPA: Missed #AHA23? If you prescribe PCSK9i mAbs, you know q2week can lead to missed doses (e.g., vacation, travel, life)...)…
9,815 followers
Missed #AHA23? If you prescribe PCSK9i mAbs, you know q2week can lead to missed doses (e.g., vacation, travel, life)...) REMAIN-2 with recaticimab is an intriguing phase1b/2 dosing trial. Look at 450 mg q12 weeks. Congrats to pts and investigators! ht